Ledger.Open graph →
SEC Form D · filed February 7, 2022

TITAN PHARMACEUTICALS INC

Offering
$7.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Katherine B. Devarney · SAN FRANCISCO, CAExec · DirectorMarc Rubin · SAN FRANCISCO, CAExec · DirectorM. D. Mcfarlane · SAN FRANCISCO, CADirectorJames R. Mcnab, Jr · SAN FRANCISCO, CADirectorJoseph A. Akers · SAN FRANCISCO, CADirectorJonathan Huang · San Francisco, CAExec · DirectorKristor Gervat · New York, NYExec · DirectorJames R. Mcnab, Jr · SAN FRANCISCO, CADirectorReid C. Covington · Key Largo, FLDirectorM. D. Mcfarlane · SAN FRANCISCO, CADirectorAlex Appleton · London, United KingdomDirectorMatthew Shaw · London, United KingdomExec · DirectorSarah Gow · London, United KingdomDirectorMaria Perrella · London, United KingdomExec · DirectorPeter Wall · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗